Ownership and insider activity for MiniMed Group, Inc. (MMED): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories.
Price
| Price | $19.25 (closing price, October 29, 2026) |
| Market Cap | $5.4B |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-10-01 | Denton Sheila A. | A-Award | 58,939 | |
| 2026-09-25 | Denton Sheila A. | |||
| 2026-07-31 | Wills Courtney Nelson | F-InKind | 1,762 | $32K |
| 2026-07-31 | Dianaty Ali | F-InKind | 8,012 | $145K |
| 2026-07-31 | Dallara Que | F-InKind | 31,350 | $569K |
| 2026-07-28 | Spooner Chad | F-InKind | 23,301 | $412K |
| 2026-07-28 | Chandrasena Gillian | F-InKind | 2,099 | $37K |
| 2026-03-25 | Dallara Que | F-InKind | 4,809 | $78K |
| 2026-03-11 | Gyurci John | A-Award | 15,322 | |
| 2026-03-11 | Chandrasena Gillian | A-Award | 58,825 |
Balance Sheet (10y)
| Year | 2024 | 2025 | 2026 |
|---|---|---|---|
| Cash & Equivalents | $54.0M | $11.0M | $298.0M |
| Short-term Investments | 0 | 0 | 0 |
| Receivables | $507.0M | $570.0M | $655.0M |
| Inventory | $292.0M | $310.0M | $341.0M |
| Total Current Assets | $895.0M | $939.0M | $1.35B |
| Property, Plant & Equipment | $636.0M | $706.0M | $711.0M |
| Goodwill | $2.25B | $2.25B | $2.26B |
| Intangible Assets | $160.0M | $131.0M | $106.0M |
| Total Assets | $4.09B | $4.20B | $4.63B |
| Accounts Payable | $190.0M | $205.0M | $163.0M |
| Short-term Debt | 0 | 0 | $137.0M |
| Total Current Liabilities | $518.0M | $710.0M | $702.0M |
| Long-term Debt | 0 | 0 | 0 |
| Total Liabilities | $646.0M | $870.0M | $1.02B |
| Retained Earnings | 0 | 0 | -$116.0M |
| Total Equity | $3.45B | $3.33B | $3.61B |
| Total Debt | $8.0M | $11.0M | $145.0M |
| Net Debt | -$46.0M | 0 | -$153.0M |
| Working Capital | $377.0M | $229.0M | $646.0M |
Financial Health
| Debt / Equity | 0.02 |
| Current Ratio | 1.81 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 2.83 |
Profitability
| Return on Equity | -9.11% |
| Return on Invested Capital | 0.43% |
| Return on Assets | -6.97% |
| Gross Margin | 53.85% |
| Operating Margin | 0.53% |
| Net Margin | -10.21% |
Related companies: DXCM · PODD · MDT · 0J5Q.L
Explore sector: Healthcare · Medical - Equipment & Services
More sections of MMED: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks